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background:  The total artificial heart(TAH) is a self-contained mechanical circulatory device designed to temporarily support the failing heart as a 
bridge to transplantation. We examined the clinical outcomes of the first 22 patients treated with the total artificial heart at Cedars-Sinai.
Methods:  22 patients with end-stage NYHA Class IV heart failure who were referred for cardiac transplantation underwent surgical implantation 
of the Syncardia TAH (Syncardia Systems, Tucson, AZ) at Cedars-Sinai Medical Center as a bridge to transplantation. All patients underwent pre-
operative transthoracic echocardiography and had intra-operative transesophageal echocardiography. Clinical outcomes including death and the 
incidence of stroke at 60 days post-TAH implantation was evaluated in all patients.
results:  Of 22 patients studied, all patients had end-stage cardiomyopathy with a mean LV end diastolic dimension of 60 ± 18 mm and a 
mean LV ejection fraction of 24 ±13% on preoperative transthoracic echocardiography. Right ventricular function was normal in 5 patients, mildly 
depressed in 9 patients, moderately depressed in 2 patients, and severely depressed in 6 patients. There were a total of 7 deaths (32%), 5(23%) of 
which occurred within 60 days. Three patients (14%) had cerebrovascular accidents and 5 patients successfully underwent cardiac transplantation, 
while the remaining 10 patients are alive and awaiting a donor organ. We were able to discharge 8 (36%) of the patients home with a portable home 
drive-line (The Freedom Driver). There were no TAH-associated infections in the population studied.
conclusions:  This is the largest single center series of patients treated with the total artificial heart that has been reported to date. Our 
data demonstrates that the total artificial heart is a highly efficacious tool to bridge end-stage heart failure patients to cardiac transplantation. 
Furthermore, it allows the clinician to discharge patients home to await transplant.
